188 related articles for article (PubMed ID: 26842163)
1. Clinical and microbiological profile of febrile neutropenia in solid tumors and hematological malignancies at a tertiary cancer care center in South India.
Jacob LA; Lakshmaiah KC; Govindbabu K; Suresh TM; Lokanatha D; Sinha M; Vijaykumar BR; Sumathi BG; Jayashree RS
Indian J Cancer; 2014; 51(4):464-8. PubMed ID: 26842163
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
[TBL] [Abstract][Full Text] [Related]
3. Pattern of bloodstream infections in patients with hematological malignancies in a tertiary care centre.
Bansal S; Advani SH
Indian J Cancer; 2014; 51(4):447-9. PubMed ID: 26842155
[TBL] [Abstract][Full Text] [Related]
4. Pattern of infection, therapy, outcome and risk stratification of patients with febrile neutropenia in a tertiary care oncology hospital in India.
Noronha V; Joshi A; Patil VM; Bhosale B; Muddu VK; Banavali S; Kelkar R; Prabhash K
Indian J Cancer; 2014; 51(4):470-4. PubMed ID: 26842166
[TBL] [Abstract][Full Text] [Related]
5. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
[TBL] [Abstract][Full Text] [Related]
10. An audit of febrile neutropenia cases from a rural cancer center in India.
Patil VM; Chakarborty S; Kumar MS; Geetha M; Dev S; Samuel S; Ahmed G; Nayanar SK; Vineetha R; Nair CK
Indian J Cancer; 2014; 51(4):487-90. PubMed ID: 26842173
[TBL] [Abstract][Full Text] [Related]
11. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiology of febrile neutropenia in adult patients with hematologic neoplasms in a period of 26 months in Hospital Pablo Tobón Uribe, Colombia].
Madrid C; Díaz L; Combariza J; Gálvez K; Olaya V; Ramírez I; Donado J
Rev Chilena Infectol; 2013 Apr; 30(2):195-201. PubMed ID: 23677158
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of High Risk Patients with Febrile Neutropenia at a Tertiary Care Center.
Osmani AH; Jabbar AA; Gangwani MK; Hassan B
Asian Pac J Cancer Prev; 2017 Oct; 18(10):2741-2745. PubMed ID: 29072402
[TBL] [Abstract][Full Text] [Related]
14. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
15. Prospective Evaluation of Infection Episodes in Cancer Patients in a Tertiary Care Academic Center: Microbiological Features and Risk Factors for Mortality.
Çalık Başaran N; Karaağaoğlu E; Hasçelik G; Durusu Tanrıöver M; Akova M
Turk J Haematol; 2016 Dec; 33(4):311-319. PubMed ID: 27095391
[TBL] [Abstract][Full Text] [Related]
16. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
Trecarichi EM; Pagano L; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Caira M; Spadea A; Busca A; Vianelli N; Tumbarello M;
Clin Microbiol Infect; 2015 Apr; 21(4):337-43. PubMed ID: 25595706
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
[TBL] [Abstract][Full Text] [Related]
18. Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients.
Lakshmaiah KC; Malabagi AS; Govindbabu ; Shetty R; Sinha M; Jayashree RS
J Lab Physicians; 2015; 7(2):116-20. PubMed ID: 26417163
[TBL] [Abstract][Full Text] [Related]
19. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
[TBL] [Abstract][Full Text] [Related]
20. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]